For instance, use of axitinib, the VEGFR inhibitor declined MDSCs while induced CD8 T cell infiltration to melanoma [81, 82]; cabozantinib, a multikinase inhibitor perturbated the immune cells subset and reduced MDSCs and regulatory T cells in spleen [83]. The gene discussed is CD8A; the disease is melanoma.